In this clinical trial, OPV, IPV and Pentavalent (DTwP, HepB and Hib) vaccines were administered concurrently with ROTAVAC 5D. Three doses of ROTAVAC 5D can be safely administered with three doses of pentavalent vaccine and three doses of OPV as well as IPV without diminishing the antibody response to each component of these vaccines. It is well tolerated when administered concomitantly with routine childhood vaccines.